ArticleExpert opinion on therapeutic patents2025

A patent review of von Hippel-Lindau (VHL)-recruiting chemical matter: E3 ligase ligands for PROTACs and targeted protein degradation (2019-present).

Aina Urbina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.